NowoTrade

ONMD

ONMD OneMedNet Corporation

Stock · NasdaqCM · United States · Healthcare · US68270C2026

NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by OneMedNet Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.

Price 5.14 USD +23.26%
52-week range 3.61 – 23.00
Dividend yield—
Market cap29.9M
NowoTrade score 3 Grade B

Price history

Daily prices in USD.

Updated 08 Nov 2026 14:36. Information, not advice.

Results

Next results —No date announced yet
Last results —Nothing reported yet
Beat the estimate — 
Average surprise — reported against the estimate, last 0 quarters

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 1.4M +111.4% -2.8M -206.1% -0.06 +83.3% -7.5M
2024 643K -37.0% -10.1M -1,575.3% -0.36 +92.3% -7M
2023 1M -11.4% -33.8M -3,308.5% -4.65 +38.4% -4.8M
2022 1.2M — -30.5M -2,641.0% -7.55 — -4.8M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by week
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
02 Dec 2024 – 06 Dec 2024 9.20 12.80 8.42 9.34 -0.64% 362,550
25 Nov 2024 – 29 Nov 2024 8.31 10.70 8.30 9.40 +6.21% 51,200
18 Nov 2024 – 22 Nov 2024 8.20 9.20 8.08 8.85 +1.03% 38,320
11 Nov 2024 – 15 Nov 2024 7.40 10.50 7.28 8.76 +23.38% 870,390
04 Nov 2024 – 08 Nov 2024 8.39 8.50 6.06 7.10 -12.56% 37,470
28 Oct 2024 – 01 Nov 2024 9.20 9.66 7.74 8.12 -10.77% 33,840
21 Oct 2024 – 25 Oct 2024 6.80 9.10 6.80 9.10 +31.88% 44,600
14 Oct 2024 – 18 Oct 2024 6.80 7.16 6.54 6.90 +4.55% 28,080
07 Oct 2024 – 11 Oct 2024 5.91 8.79 5.87 6.60 +11.86% 83,100
30 Sep 2024 – 04 Oct 2024 6.08 6.33 5.60 5.90 -5.75% 28,670
23 Sep 2024 – 27 Sep 2024 6.64 6.70 5.48 6.26 -2.34% 91,060
16 Sep 2024 – 20 Sep 2024 7.40 7.70 6.19 6.41 -16.64% 64,050
09 Sep 2024 – 13 Sep 2024 9.40 9.50 7.10 7.69 -16.41% 43,630
03 Sep 2024 – 06 Sep 2024 10.70 10.70 8.80 9.20 -10.68% 20,640
26 Aug 2024 – 30 Aug 2024 10.30 10.82 9.70 10.30 0.00% 38,020
19 Aug 2024 – 23 Aug 2024 12.60 13.80 9.50 10.30 -21.37% 88,850
12 Aug 2024 – 16 Aug 2024 11.60 14.10 10.60 13.10 +23.58% 125,970
05 Aug 2024 – 09 Aug 2024 10.90 12.45 9.32 10.60 -14.52% 124,960
29 Jul 2024 – 02 Aug 2024 9.90 16.00 9.00 12.40 +25.00% 696,960
22 Jul 2024 – 26 Jul 2024 9.20 13.50 7.86 9.92 +9.01% 1,024,120
15 Jul 2024 – 19 Jul 2024 10.80 11.20 9.10 9.10 -16.51% 66,460
08 Jul 2024 – 12 Jul 2024 9.30 13.11 8.90 10.90 +22.75% 325,990
01 Jul 2024 – 05 Jul 2024 9.61 9.83 8.51 8.88 -9.66% 33,200
24 Jun 2024 – 28 Jun 2024 11.50 11.50 8.39 9.83 -15.26% 119,830
17 Jun 2024 – 21 Jun 2024 11.30 13.00 10.50 11.60 -3.33% 133,170

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
4.17 USD
Market cap
29.9M
Exchange
NasdaqCM
Country
United States
Sector
Healthcare
Industry
Health Information Services
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 9.4 / 25
  • Revenue growth of 5.6% a year
Quality Return on equity, net margin and how stable the margins are. 0.0 / 25 —
Financial strength Net debt against operating earnings, interest cover and free cash flow. 0.0 / 20
  • Free cash flow yield of -14.1%
Valuation Free cash flow yield and the P/E against its sector. 0.0 / 15
  • Price / sales 20.6: it has no profit to price yet
Analysts How far the analysts' average target is from today's price. 3.5 / 10 No figures for this part: it counts as a cautious 35%. —
  • Score capped at 60: free cash flow was negative in two of the last three years
  • Thin interest cover: operating profit is only -144.3× the interest
  • The last full year was a loss

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 85% of the figures (grade B). Warnings take 12 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.

Figures

Valuation
FigureValueReading Sector median
Price / book -8.44× Weak 3.8×
Price / sales 20.58× Weak 3.19×
EV / EBITDA -3.05× Weak 12.61×
Free cash flow yield -14.1% Weak 2.5%
Quality
FigureValueReading Sector median
Gross margin -83.3% Weak 58.6%
Operating margin -774.3% Weak 7.6%
Net margin 0% Weak 2.7%
Return on assets -342.1% Weak 3.5%
Growth
FigureValueReading Sector median
Revenue growth / year 5.6% Fair 10.8%
Financial health
FigureValueReading Sector median
Debt / equity -0.19× Good 0.48×
Interest cover -144.28× Weak 2.65×
Current ratio 0.28× Weak 2.36×

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Follow ONMD and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in